Chronic granulomatous disease

Active Research Protocols

  1. 05-I-0213 – Screening and Baseline Assessment of Patients with Abnormalities of Immune Function
  2. 06-I-0217 – Genetic Disorders of Mucociliary Clearance
  3. 07-I-0017 – Autologous Transplantation of Genetically Modified Cells for the Treatment of X-Linked Chronic Granulomatous Disease
  4. 07-I-0033 – Screening Protocol for Detection and Characterization of Infections and Infection Susceptibility
  5. 07-I-0075 – Allogeneic and Matched Unrelated Donor Stem Cell Transplantation for Congenital Immunodeficiencies or Patients with Autoinflammatory/Immunodysregulatory Conditions: Busulfan-Based Conditioning with Campath- 1H or h-ATG, Radiation, and Sirolimus
  6. 07-I-0142 – Research Respiratory Tract Procedures
  7. 10-I-0029 – Non-Invasive Assessment of Atherosclerosis in Patients with CGD and Other Disorders of the Immune System
  8. 10-I-0123 – Assessment of the Biochemical Response to Interferon-Gamma in Subjects with Specific Gene Mutation in Chronic Granulomatous Disease
  9. 10-I-0216 – Studies of Disorders with Increased Susceptibility to Fungal Infections
  10. 13-I-0117 – Radiofrequency Ablation (RFA) for the Treatment of Liver Abscesses in Patients with Chronic Granulomatous Disease
  11. 82-I-0183 – Study of the Immune Regulation of Idiopathic Inflammatory Bowel Diseases: Crohn's Disease, Ulcerative Colitis, and Other Inflammatory Conditions of the Gut
  12. 94-I-0073 – Recruitment and Apheresis Collection of Peripheral Blood Hematopoietic Stem Cells
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014